Ryan Basom
Overview
Explore the profile of Ryan Basom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
897
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gauthier J, Liang E, Huang J, Kimble E, Hirayama A, Fiorenza S, et al.
Blood Adv
. 2025 Jan;
PMID: 39820359
CD19-directed chimeric antigen receptor-engineered (CD19 CAR) T-cell therapy elicits high response rates but fails to induce durable responses in most adults with relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia...
2.
Liang E, Huang J, Portuguese A, Ortiz-Maldonado V, Albittar A, Wuliji N, et al.
Blood Adv
. 2024 Dec;
9(3):606-616.
PMID: 39626349
Immune effector cell-associated hematotoxicity (ICAHT) is associated with morbidity and mortality after chimeric antigen receptor (CAR) T-cell therapy. To date, the factors associated with ICAHT are poorly characterized, and there...
3.
Vo P, Sandmaier B, Othus M, Ali N, Rodriguez-Arboli E, Orvain C, et al.
Res Sq
. 2024 Nov;
PMID: 39606437
Methodological advancements now allow older adults with AML to receive allografts although conflicting data exist regarding relative outcomes across age groups and benefits of different conditioning intensities. We retrospectively analyzed...
4.
Ali N, Othus M, Rodriguez-Arboli E, Orvain C, Milano F, Sandmaier B, et al.
Blood Adv
. 2024 Oct;
9(3):558-570.
PMID: 39374582
Measurable residual disease (MRD) by multiparametric flow cytometry (MFC) before allogeneic hematopoietic cell transplantation (HCT) identifies patients at high risk of acute myeloid leukemia (AML) relapse, often occurring early after...
5.
Rodriguez-Arboli E, Othus M, Orvain C, Ali N, Milano F, Davis C, et al.
Transplant Cell Ther
. 2024 Jun;
30(9):905.e1-905.e14.
PMID: 38914227
Second allogeneic hematopoietic cell transplantation (HCT2) is potentially curative for adults with acute myeloid leukemia (AML) or myelodysplastic neoplasm (MDS)/AML experiencing relapse after a first allograft (HCT1), but prognostic factors...
6.
Yeung C, Woolston D, Wu V, Voutsinas J, Basom R, Davis C, et al.
Eur J Haematol
. 2023 Aug;
112(1):111-121.
PMID: 37526606
Background: Bone marrow (BM) assessment after CAR-T cell immunotherapy infusion is not routinely performed to monitor adverse events such as cytopenias, hemophagocytic lymphohistiocytosis, or infections. Our institution has performed BM...
7.
Avery J, Guffey D, Ma S, Basom R, Lee S, Garcia D, et al.
Thromb Res
. 2023 Jun;
229:1-6.
PMID: 37356171
Introduction: Patients undergoing allogenic hematopoietic stem cell transplantation (allo-HSCT) require indwelling central venous catheters. The comparative incidence, risk, and outcome of isolated catheter-related deep venous thrombosis (CR-DVT) versus pulmonary embolism/lower-extremity...
8.
Li A, Martens K, Nguyen D, Basom R, Rondon G, Jin S, et al.
Am J Hematol
. 2022 Mar;
97(6):740-748.
PMID: 35266218
In patients undergoing hematopoietic cell transplantation (HCT), venous thromboembolism (VTE) remains a serious complication that lacks validated risk assessment models (RAMs) to guide thromboprophylaxis. To address this dilemma, we performed...
9.
OConnor S, Feldman H, Arora S, Hoellerbauer P, Toledo C, Corrin P, et al.
Mol Syst Biol
. 2021 Jun;
17(6):e9522.
PMID: 34101353
Single-cell RNA sequencing has emerged as a powerful tool for resolving cellular states associated with normal and maligned developmental processes. Here, we used scRNA-seq to examine the cell cycle states...
10.
Martens K, Amos C, Rojas Hernandez C, Kebriaei P, da Costa Jr. W, Basom R, et al.
Am J Hematol
. 2021 Jun;
96(9):1137-1146.
PMID: 34097772
History of venous thromboembolism (VTE) is prevalent among patients undergoing hematopoietic cell transplantation (HCT). Management of anticoagulation is particularly challenging as most patients will have chemotherapy-induced thrombocytopenia while awaiting engraftment...